Testing effectiveness (Phase 2)Study completedNCT01130805What this trial is testingPazopanib With CAPEOX in AGC PatientsWho this might be right forGastric Cancer Samsung Medical Center 66
Testing effectiveness (Phase 2)UnknownNCT00985556What this trial is testingOxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric CancerWho this might be right forGastric Cancer Yonsei University 130
Not applicableStudy completedNCT01846520What this trial is testingFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersWho this might be right forHealthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more City of Hope Medical Center 200
Early research (Phase 1)Study completedNCT00089362What this trial is testingAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forMale Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT00683787What this trial is testingDocetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction CancerWho this might be right forGastric Cancer Roswell Park Cancer Institute 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04550494What this trial is testingMeasuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate Carcinoma+28 more National Cancer Institute (NCI) 29
Not applicableLooking for participantsNCT07243015What this trial is testingDetection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis MarkersWho this might be right forGastric Cancer City of Hope Medical Center 500
Early research (Phase 1)Ended earlyNCT04187872What this trial is testingLITT and Pembrolizumab in Recurrent Brain MetastasisWho this might be right forMelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more University of Florida 10
Testing effectiveness (Phase 2)Study completedNCT00061932What this trial is testingBortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or StomachWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+5 more National Cancer Institute (NCI) 41
Large-scale testing (Phase 3)UnknownNCT02509806What this trial is testingApatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric CancerWho this might be right forGastric Cancer Hebei Medical University 48
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT00313599What this trial is testingLapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsWho this might be right forBladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more University of California, San Francisco 28
Not applicableUnknownNCT02431078What this trial is testingThe Expression of ZEB1 in CTCs Associated With Metastasis and Recurrence for Gastric CancerWho this might be right forStomach Neoplasms wei bo 100
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT00154726What this trial is testingPaclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric CancersWho this might be right forLocally Advanced and Recurrent/Metastatic Gastric Cancer National Taiwan University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Study completedNCT00382720What this trial is testingDocetaxel and Oxaliplatin in Gastric CancerWho this might be right forStomach Neoplasms Sanofi 275
Testing effectiveness (Phase 2)UnknownNCT00004236What this trial is testingLiposomal Doxorubicin in Treating Patients With Advanced Stomach CancerWho this might be right forEsophageal CancerGastric Cancer University of Leicester
Testing effectiveness (Phase 2)Study completedNCT01364493What this trial is testingEvaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric CancerWho this might be right forGastric Cancer Peking University 51
Testing effectiveness (Phase 2)UnknownNCT01491217What this trial is testingOraxol® in Gastric Cancer PatientsWho this might be right forAdvanced Metastatic Gastric CancerRecurrent Gastric Cancer Hanmi Pharmaceutical Company Limited 53